Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

Addition of pembrolizumab to chemotherapy in patients with TKI-resistant, <i>EGFR</i>-mutant, metastatic nonsquamous NSCLC did not significantly prolong PFS or OS versus placebo plus chemotherapy in KEYNOTE-789.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-08-22
DOI
https://doi.org/10.1200/jco.23.02747
Citations
126
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
50.27

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

Phillip Parente, Fernanda Maris Peria, Silvia Novello, Filippo de Marinis et al.
126 citations
Journal of Clinical Oncology
Lung Cancer Treatments and Mutations
50.27
article

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

Phillip Parente, Fernanda Maris Peria, Silvia Novello, Filippo de Marinis, Jair Bar, Rina Hui, Shun Lü, Rachel E. Sanborn, Ki Hyeong Lee, Pedro Rafael Martins De Marchi, David Vicente, Yuichi Tambo, Natasha B. Leighl, Masashi Kondo, Toshiaki Takahashi, Sivan Shamai, Kazuo Kasahara, Takako Inoue, Nagashree Seetharamu, Jin Hyoung Kang, Sandeep H. Mashru, Domenico Galetta, Kazuma Kishi, Francesca Mazzoni, Ji‐Youn Han, Helong Zhang, Francesco Di Costanzo, Kam Zaki, Dae Ho Lee, Daniel C. Christoph, Andrew Mant, R. Öhman, Qiming Wang, Manuel Cobo, Bruno Coudert, Wu‐Chou Su, Yoshitsugu Horio, Julien Dutilh, Keunchil Park, Cheng‐Ta Yang, Martin Wermke, Hiroshige Yoshioka, Janakiraman Subramanian, Chun‐Yao Huang, Hans‐Georg Kopp, Yu Yao, Jason Agulnik, Emmanuel de la Mora Jimenez, Noam Asna, Thomas Newsom-Davis, Leandro Brust, Maya Gottfried, Laura Doni, Rainer Wiewrodt, Sing Hung Lo, Dan Costin, Gongyan Chen, Jonathan Shamash, M. Pérol, Hiroaki Takeoka, Eiji Iwama, Bengt Bergman, Luis Paz-Ares Rodríguez, Francesco Ferraù, Julien Dômont, Eiki Ichihara, Pilar Garrido, Dionysis Papadatos-Pastos, Youssef Oulkhouir, Jianying Zhou, Jih‐Hsiang Lee, Kiyotaka Yoh, Frank Griesinger, Yukio Hosomi, James Chih‐Hsin Yang, Annette Mueller, Masao Ichiki, Keisuke Kirita, Parneet Kaur Cheema, Stanislas Ropert, Margarita Majem, Giuseppe Tonini, Jens Kern, Gregory J. Riely, Sérgio Jobim Azevedo, Alona Zer, Shunsuke Teraoka, Takayasu Kurata, Se‐Hoon Lee, Jerónimo Rafael Rodríguez Cid, Kejing Ying, Ian Anderson, M. Catherine Pietanza, Chao‐Hua Chiu, Daiya Takai, Fábio Franke, Isamu Okamoto, Jerónimo Rafael Rodríguez‐Cid, Richard D. Hall, Gee‐Chen Chang, Anders Vikström, Te‐Chun Hsia, Melanie Mackean, Toshiyuki Kozuki, Diana Chirovsky, Michael Boyer, Donald B. Wender, Julia Dudnik, Fabiana Vitiello, Gustavo Werutsky, Francovito Piantedosi, Ambika Parmar, Ronald B. Natale, Chung Man James Ho, Viola W. Zhu, Dominique Spaeth, Gilberto de Castro, Toyoaki Hida, Lin Wu, Makenzi Colleen Evangelist, Sagun Parakh, Sai‐Hong Ignatius Ou, Claas Wesseler, Ines B. Menjak, Thomas John, Mark Doherty, D. Carmier, Xiangdong Zhou, Hisashi Takaya, Yuichiro Ohe, Terufumi Kato, Enric Carcereny, Jonathan E. Dowell, Chin-Chou Wang, Li Zhang, Ge Li, Xin Zhang, Saad A. Khan, Jong‐Seok Lee, Cheng Zhi Huang, Yun Fan, Ji‐Feng Feng, Victor Lee, Ahmad Raza, Yoshihiro Hattori, Pooja Jain, Ying Cheng, Zhigang Han, Hiroshi Tanaka, Hideo Saka, Ziping Wang, Toru Kumagai, Jianying Zhou, Yingying Du, Tsung‐Ying Yang, Yiwen Luo, Shobhit Baijal, Virginie Westeel, Jiuwei Cui, E. Felip Font, Smitha Menon, Corinne Lamour, Hsu-Ching Huang, Jian Su, Kang‐Yun Lee, Simon Ekman, C.A. Hernández, Laura Stampleman, Niyati Bhagwati, Joilda Batista De Almeida Rego, Dong‐Wan Kim, Chengping Hu, G Vogel, Aurélie Lagrange, Eun Kyung Cho, Young Joo Min, Sheng-Hao Lin, Chih-Bin Lin, Gustavo Dix Junqueira, Mark E. Wong, Mirjana Wollner, Nicholas Campbell, Shang-Yin Wu, Stephan DiSean Kendall, Ofer Rotem, David Vicente Baz, Mhameed Kamel, Shi Feng Jonathan Nyaw, Yu Chung Jacky Li, Juliet Brock, Samreen Ahmed, Óscar Gerardo Arrieta Rodríguez, Mor Moskovitz, Siu Hong Oscar Chan, Masahide Oki, Yan Wang, Yong Zhang
article en
126 citations

Abstract

Addition of pembrolizumab to chemotherapy in patients with TKI-resistant, <i>EGFR</i>-mutant, metastatic nonsquamous NSCLC did not significantly prolong PFS or OS versus placebo plus chemotherapy in KEYNOTE-789.

Journal of Clinical OncologyVol. 42(34)
Ulsan College (KR), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Memorial Sloan Kettering Cancer Center (US), Kyushu University (JP), Shanghai Jiao Tong University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), Asan Medical Center (KR), Shanghai Chest Hospital (CN), Seoul National University Bundang Hospital (KR), University of Ulsan (KR), Hospital Universitario Virgen Macarena (ES), Taoyuan Chang Gung Memorial Hospital (TW), Zhejiang Cancer Hospital (CN), Okayama University Hospital (JP), Hospital Médica Sur (MX), Centre Léon Bérard (FR), Istituto Oncologico Veneto (IT), National Taiwan University Hospital (TW), Instituto Jalisciense de Cancerología (MX), Osaka International Cancer Institute (JP), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Chungbuk National University Hospital (KR), First Affiliated Hospital Zhejiang University (CN), European Institute of Oncology (IT)
Eli Lilly and Company
Good health and well-being
Openalex Percentile: Top 0%
Lung Cancer Treatments and Mutations
50.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.